En 2022, la FDA emiti advertencias contra varias empresas que comercializaban pptidos, incluido el BPC-157, como productos teraputicos sin autorizacin
Vitamin C (L-ascorbic acid) destabilizes copper peptides
Users often see early changes such as improved smoothness and brightness before more visible tone refinement appears
Freedom from worrying that the medicine will stop working once you stop taking it
a survival plot for MOF on a non-matched dataset was also produced ( For the primary analysis, we used the Cox proportional hazards model to estimate hazard rate ratios (HRs) for fracture between the exposure and the control groups
Price parity hands Lilly the advantage Because Medicare Part D plans can cover both drugs equally, it removes those pesky formulary barriersthe insurance obstacles that make one drug harder to access even when both are covered. In my view, this sets up tirzepatide perfectly: it delivers better weight-loss outcomes with lower GI discontinuation rates in head-to-head trials in SURMOUNT-5
